The deuterated form of deupirfenidone produced favorable results in an open-label extension study. Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease marked by irreversible ...

An expert discusses how primary and secondary prevention differ in atherosclerotic cardiovascular disease, with secondary prevention targeting patients who have already had events such as heart ...

Amneal submits a BLA for a new Xolair biosimilar, promising affordable treatment options for asthma and allergies, enhancing ...

Novartis said that it is exploring an additional direct-to-employer model to increase access and affordability for cash-paying patients in the United States.

If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 ...

We’ll be back on Monday morning with more fresh content!

Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more ...

The short-term study is believed to be the first to evaluate both interventions combined for people with mental illness.

Today’s announcement builds on a previous announcement of more than 40% off the Eliquis list price, a direct-to-consumer ...

AstraZeneca will launch a new online platform to make Airsupra, as well as Farxiga and Flumist, available for home delivery ...

The expiration of ACA tax credits threatens $32 billion in healthcare revenue, risking coverage for millions and increasing ...

Evkeeza is now approved for the treatment of homozygous familial hypercholesterolemia (HoFH) in patients as young as 1 year ...